Mapping the Gut: A New Atlas Illuminates the Path to Understanding and Treating Cancer (and other diseases)
/0 Comments/in Not PCa related, Preclinical Research/by MaxPreclinical: A More Efficient and Selective Path to Anti-Cancer Drugs
/0 Comments/in Preclinical Research/by MaxA New Wave in Bone Grafting: Coral-Inspired Material Offers Hope for Faster Healing
/0 Comments/in Preclinical Research/by MaxActivating GP130 Protein Shows Promise in Prostate Cancer Treatment
/0 Comments/in Preclinical Research/by MaxAPVO442: A Promising New Bispecific Antibody for Prostate Cancer Treatment
/0 Comments/in Preclinical Research/by MaxInhibition of SREBP Reinduces Docetaxel Sensitivity in Advanced Prostate Cancer
/0 Comments/in Preclinical Research/by MaxKaempferol: A Potential Treatment for Emotional Stress-Aggravated Prostate Cancer Metastasis
/0 Comments/in Preclinical Research/by MaxProtac NP18: A New Hope for Prostate Cancer Treatment
/0 Comments/in Preclinical Research, PROTACs/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy castration-resistant prostate cancer CDK12 clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology olaparib oncolytic virus personalized medicine prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 23/2025 June 8, 2025
- Protein Design Leaps Forward Thanks to AI June 5, 2025
- Phase 1 Trial of XL309: USP1 Inhibitor Targeting DNA Repair in Solid Tumors June 5, 2025
- UPDATE About ACE-232: Phase 1 Trial of a Novel CYP11A1 Inhibitor for mCRPC June 5, 2025